APO RESEARCH · REPORT
Animal Stem Cell Therapy
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Product & engineering
Understand the product.
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Selected research
Market Structure
Global Animal Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.
Read the full market overview
Report Includes
This report provides an overview of the global Animal Stem Cell Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Animal Stem Cell Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Animal Stem Cell Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Animal Stem Cell Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.
Animal Stem Cell Therapy Segment by Company
Medivet Biologics LLC
VETSTEM BIOPHARMA
J-ARM
U.S. Stem Cell, Inc
VetCell Therapeutics
Celavet Inc.
Magellan Stem Cells
Kintaro Cells Power
Animal Stem Care
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Animal Stem Cell Therapy Segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others Animals
Animal Stem Cell Therapy Segment by Application
Veterinary Hospitals
Research Organizations
Animal Stem Cell Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Stem Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Animal Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Stem Cell Therapy industry.
Chapter 3: Detailed analysis of Animal Stem Cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Stem Cell Therapyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dogs Stem Cell Therapy
- Horses Stem Cell Therapy
- Others Animals
Applications
- Veterinary Hospitals
- Research Organizations
Companies covered
- Medivet Biologics LLC
- VETSTEM BIOPHARMA
- J-ARM
- U.S. Stem Cell, Inc
- VetCell Therapeutics
- Celavet Inc.
- Magellan Stem Cells
- Kintaro Cells Power
- Animal Stem Care
- Animal Cell Therapies
- Cell Therapy Sciences
- Animacel
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Animal Stem Cell Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Dogs Stem Cell Therapy
- 1.2.3 Horses Stem Cell Therapy
- 1.2.4 Others Animals
- 1.3 Market Analysis by Application
- 1.3.1 Global Animal Stem Cell Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Veterinary Hospitals
- 1.3.3 Research Organizations
- 1.4 Global Market Growth Prospects
- 1.5 Global Animal Stem Cell Therapy Growth Trends by Region
- 1.5.1 Global Animal Stem Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Animal Stem Cell Therapy Market Size by Region (2021-2026)
- 1.5.3 Animal Stem Cell Therapy Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Animal Stem Cell Therapy Market Dynamics
- 2.1 Animal Stem Cell Therapy Industry Trends
- 2.2 Animal Stem Cell Therapy Industry Drivers
- 2.3 Animal Stem Cell Therapy Industry Opportunities and Challenges
- 2.4 Animal Stem Cell Therapy Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Animal Stem Cell Therapy Revenue by Company (2021-2026)
- 3.2 Global Animal Stem Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Animal Stem Cell Therapy Key Company Head office and Area Served
- 3.4 Global Animal Stem Cell Therapy Company, Product Type & Application
- 3.5 Global Animal Stem Cell Therapy Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Animal Stem Cell Therapy Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Animal Stem Cell Therapy Players Market Share by Revenue in 2025
- 3.6.3 2025 Animal Stem Cell Therapy Tier 1, Tier 2, and Tier 3
4 Animal Stem Cell Therapy Market by Type
- 4.1 Global Animal Stem Cell Therapy Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Animal Stem Cell Therapy Market Size by Type (2021-2032)
- 4.3 Global Animal Stem Cell Therapy Market Size Share by Type (2021-2032)
5 Animal Stem Cell Therapy Market by Application
- 5.1 Global Animal Stem Cell Therapy Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Animal Stem Cell Therapy Market Size by Application (2021-2032)
- 5.3 Global Animal Stem Cell Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Medivet Biologics LLC
- 6.1.1 Medivet Biologics LLC Company Information
- 6.1.2 Medivet Biologics LLC Business Overview
- 6.1.3 Medivet Biologics LLC Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Medivet Biologics LLC Animal Stem Cell Therapy Product Portfolio
- 6.1.5 Medivet Biologics LLC Recent Developments
- 6.2 VETSTEM BIOPHARMA
- 6.2.1 VETSTEM BIOPHARMA Company Information
- 6.2.2 VETSTEM BIOPHARMA Business Overview
- 6.2.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 VETSTEM BIOPHARMA Animal Stem Cell Therapy Product Portfolio
- 6.2.5 VETSTEM BIOPHARMA Recent Developments
- 6.3 J-ARM
- 6.3.1 J-ARM Company Information
- 6.3.2 J-ARM Business Overview
- 6.3.3 J-ARM Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 J-ARM Animal Stem Cell Therapy Product Portfolio
- 6.3.5 J-ARM Recent Developments
- 6.4 U.S. Stem Cell, Inc
- 6.4.1 U.S. Stem Cell, Inc Company Information
- 6.4.2 U.S. Stem Cell, Inc Business Overview
- 6.4.3 U.S. Stem Cell, Inc Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 U.S. Stem Cell, Inc Animal Stem Cell Therapy Product Portfolio
- 6.4.5 U.S. Stem Cell, Inc Recent Developments
- 6.5 VetCell Therapeutics
- 6.5.1 VetCell Therapeutics Company Information
- 6.5.2 VetCell Therapeutics Business Overview
- 6.5.3 VetCell Therapeutics Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 VetCell Therapeutics Animal Stem Cell Therapy Product Portfolio
- 6.5.5 VetCell Therapeutics Recent Developments
- 6.6 Celavet Inc.
- 6.6.1 Celavet Inc. Company Information
- 6.6.2 Celavet Inc. Business Overview
- 6.6.3 Celavet Inc. Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Celavet Inc. Animal Stem Cell Therapy Product Portfolio
- 6.6.5 Celavet Inc. Recent Developments
- 6.7 Magellan Stem Cells
- 6.7.1 Magellan Stem Cells Company Information
- 6.7.2 Magellan Stem Cells Business Overview
- 6.7.3 Magellan Stem Cells Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Magellan Stem Cells Animal Stem Cell Therapy Product Portfolio
- 6.7.5 Magellan Stem Cells Recent Developments
- 6.8 Kintaro Cells Power
- 6.8.1 Kintaro Cells Power Company Information
- 6.8.2 Kintaro Cells Power Business Overview
- 6.8.3 Kintaro Cells Power Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Kintaro Cells Power Animal Stem Cell Therapy Product Portfolio
- 6.8.5 Kintaro Cells Power Recent Developments
- 6.9 Animal Stem Care
- 6.9.1 Animal Stem Care Company Information
- 6.9.2 Animal Stem Care Business Overview
- 6.9.3 Animal Stem Care Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Animal Stem Care Animal Stem Cell Therapy Product Portfolio
- 6.9.5 Animal Stem Care Recent Developments
- 6.10 Animal Cell Therapies
- 6.10.1 Animal Cell Therapies Company Information
- 6.10.2 Animal Cell Therapies Business Overview
- 6.10.3 Animal Cell Therapies Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Animal Cell Therapies Animal Stem Cell Therapy Product Portfolio
- 6.10.5 Animal Cell Therapies Recent Developments
- 6.11 Cell Therapy Sciences
- 6.11.1 Cell Therapy Sciences Company Information
- 6.11.2 Cell Therapy Sciences Business Overview
- 6.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Cell Therapy Sciences Animal Stem Cell Therapy Product Portfolio
- 6.11.5 Cell Therapy Sciences Recent Developments
- 6.12 Animacel
- 6.12.1 Animacel Company Information
- 6.12.2 Animacel Business Overview
- 6.12.3 Animacel Animal Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Animacel Animal Stem Cell Therapy Product Portfolio
- 6.12.5 Animacel Recent Developments
7 North America
- 7.1 North America Animal Stem Cell Therapy Market Size (2021-2032)
- 7.2 North America Animal Stem Cell Therapy Market Size by Type
- 7.2.1 North America Animal Stem Cell Therapy Market Size by Type (2021-2026)
- 7.2.2 North America Animal Stem Cell Therapy Market Size by Type (2027-2032)
- 7.2.3 North America Animal Stem Cell Therapy Market Share by Type (2021-2032)
- 7.3 North America Animal Stem Cell Therapy Market Size by Application
- 7.3.1 North America Animal Stem Cell Therapy Market Size by Application (2021-2026)
- 7.3.2 North America Animal Stem Cell Therapy Market Size by Application (2027-2032)
- 7.3.3 North America Animal Stem Cell Therapy Market Share by Application (2021-2032)
- 7.4 North America Animal Stem Cell Therapy Market Size by Country
- 7.4.1 North America Animal Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Animal Stem Cell Therapy Market Size by Country (2021-2026)
- 7.4.3 North America Animal Stem Cell Therapy Market Size by Country (2027-2032)
- 7.4.4 North America Animal Stem Cell Therapy Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Animal Stem Cell Therapy Market Size (2021-2032)
- 8.2 Europe Animal Stem Cell Therapy Market Size by Type
- 8.2.1 Europe Animal Stem Cell Therapy Market Size by Type (2021-2026)
- 8.2.2 Europe Animal Stem Cell Therapy Market Size by Type (2027-2032)
- 8.2.3 Europe Animal Stem Cell Therapy Market Share by Type (2021-2032)
- 8.3 Europe Animal Stem Cell Therapy Market Size by Application
- 8.3.1 Europe Animal Stem Cell Therapy Market Size by Application (2021-2026)
- 8.3.2 Europe Animal Stem Cell Therapy Market Size by Application (2027-2032)
- 8.3.3 Europe Animal Stem Cell Therapy Market Share by Application (2021-2032)
- 8.4 Europe Animal Stem Cell Therapy Market Size by Country
- 8.4.1 Europe Animal Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Animal Stem Cell Therapy Market Size by Country (2021-2026)
- 8.4.3 Europe Animal Stem Cell Therapy Market Size by Country (2027-2032)
- 8.4.4 Europe Animal Stem Cell Therapy Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Animal Stem Cell Therapy Market Size (2021-2032)
- 9.2 China Animal Stem Cell Therapy Market Size by Type
- 9.2.1 China Animal Stem Cell Therapy Market Size by Type (2021-2026)
- 9.2.2 China Animal Stem Cell Therapy Market Size by Type (2027-2032)
- 9.2.3 China Animal Stem Cell Therapy Market Share by Type (2021-2032)
- 9.3 China Animal Stem Cell Therapy Market Size by Application
- 9.3.1 China Animal Stem Cell Therapy Market Size by Application (2021-2026)
- 9.3.2 China Animal Stem Cell Therapy Market Size by Application (2027-2032)
- 9.3.3 China Animal Stem Cell Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Animal Stem Cell Therapy Market Size (2021-2032)
- 10.2 Asia Animal Stem Cell Therapy Market Size by Type
- 10.2.1 Asia Animal Stem Cell Therapy Market Size by Type (2021-2026)
- 10.2.2 Asia Animal Stem Cell Therapy Market Size by Type (2027-2032)
- 10.2.3 Asia Animal Stem Cell Therapy Market Share by Type (2021-2032)
- 10.3 Asia Animal Stem Cell Therapy Market Size by Application
- 10.3.1 Asia Animal Stem Cell Therapy Market Size by Application (2021-2026)
- 10.3.2 Asia Animal Stem Cell Therapy Market Size by Application (2027-2032)
- 10.3.3 Asia Animal Stem Cell Therapy Market Share by Application (2021-2032)
- 10.4 Asia Animal Stem Cell Therapy Market Size by Country
- 10.4.1 Asia Animal Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Animal Stem Cell Therapy Market Size by Country (2021-2026)
- 10.4.3 Asia Animal Stem Cell Therapy Market Size by Country (2027-2032)
- 10.4.4 Asia Animal Stem Cell Therapy Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Animal Stem Cell Therapy Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Type
- 11.2.1 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Animal Stem Cell Therapy Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Application
- 11.3.1 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Animal Stem Cell Therapy Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Country
- 11.4.1 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Animal Stem Cell Therapy Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst